Thank you!

Your email has been successfully added to our mailing list.

×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
No thanks

RVNC – revance therapeutics, inc. (US:NASDAQ)

DELAYED
$
Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low
VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
RVNC
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/18
03:07 am
rvnc
Revance Therapeutics, Inc. (NASDAQ: RVNC) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Medium Report
Revance Therapeutics, Inc. (NASDAQ: RVNC) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Report
11/11
07:25 am
rvnc
Shareholders that lost money on Revance Therapeutics, Inc.(RVNC) should contact Levi & Korsinsky about Securities Fraud Investigation - RVNC
Medium Report
Shareholders that lost money on Revance Therapeutics, Inc.(RVNC) should contact Levi & Korsinsky about Securities Fraud Investigation - RVNC
Report
11/10
11:00 am
rvnc
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Revance Therapeutics, Inc. - RVNC
High Report
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Revance Therapeutics, Inc. - RVNC
Report
11/10
02:03 am
rvnc
Revance Therapeutics, Inc. (NASDAQ: RVNC) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
High Report
Revance Therapeutics, Inc. (NASDAQ: RVNC) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Report
11/8
01:44 pm
rvnc
Revance Therapeutics, Inc. (NASDAQ: RVNC) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.
Medium Report
Revance Therapeutics, Inc. (NASDAQ: RVNC) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.
Report
11/8
12:00 pm
rvnc
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Revance Therapeutics, Inc. - RVNC
Neutral Report
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Revance Therapeutics, Inc. - RVNC
Report
11/8
11:37 am
rvnc
Revance Therapeutics, Inc. (NASDAQ: RVNC) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $6.60 price target on the stock.
Low Report
Revance Therapeutics, Inc. (NASDAQ: RVNC) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $6.60 price target on the stock.
Report
11/8
10:45 am
rvnc
Revance Stock - Investors of Revance Therapeutics Inc. Encouraged to Contact Kehoe Law Firm, P.C. - RVNC
Medium Report
Revance Stock - Investors of Revance Therapeutics Inc. Encouraged to Contact Kehoe Law Firm, P.C. - RVNC
Report
11/8
07:30 am
rvnc
Levi & Korsinsky Reminds Shareholders of an Investigation into Revance Therapeutics, Inc. (RVNC) Regarding Potential Securities Fraud Allegations
High Report
Levi & Korsinsky Reminds Shareholders of an Investigation into Revance Therapeutics, Inc. (RVNC) Regarding Potential Securities Fraud Allegations
Report
11/7
04:05 pm
rvnc
Revance Reports Third Quarter 2024 Financial Results, Provides Corporate Update
High Report
Revance Reports Third Quarter 2024 Financial Results, Provides Corporate Update
Report
11/7
07:30 am
rvnc
Levi & Korsinsky Investigates Possible Securities Fraud Violations by Revance Therapeutics, Inc. (RVNC)
Low Report
Levi & Korsinsky Investigates Possible Securities Fraud Violations by Revance Therapeutics, Inc. (RVNC)
Report
11/6
04:15 pm
rvnc
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Revance Therapeutics, Inc. - RVNC
Low Report
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Revance Therapeutics, Inc. - RVNC
Report
11/6
07:25 am
rvnc
Revance Therapeutics, Inc. (RVNC) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights
Low Report
Revance Therapeutics, Inc. (RVNC) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights
Report
11/5
07:25 am
rvnc
Revance Therapeutics, Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Revance Therapeutics, Inc. (RVNC)
Low Report
Revance Therapeutics, Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Revance Therapeutics, Inc. (RVNC)
Report
11/4
04:30 pm
rvnc
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Revance Therapeutics, Inc. - RVNC
Medium Report
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Revance Therapeutics, Inc. - RVNC
Report
11/4
07:25 am
rvnc
Revance Therapeutics, Inc. Being Investigated on Behalf of Revance Therapeutics, Inc. Investors. Contact Levi & Korsinsky For Details.
Low Report
Revance Therapeutics, Inc. Being Investigated on Behalf of Revance Therapeutics, Inc. Investors. Contact Levi & Korsinsky For Details.
Report
11/2
12:00 pm
rvnc
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Revance Therapeutics, Inc. - RVNC
Low Report
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Revance Therapeutics, Inc. - RVNC
Report
11/2
02:10 am
rvnc
Revance Therapeutics, Inc. (NASDAQ: RVNC) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Low Report
Revance Therapeutics, Inc. (NASDAQ: RVNC) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Report
11/1
07:30 am
rvnc
Revance Therapeutics, Inc. (RVNC) Shareholders May Have Been Affected by Fraud - Levi & Korsinsky Investigates
Low Report
Revance Therapeutics, Inc. (RVNC) Shareholders May Have Been Affected by Fraud - Levi & Korsinsky Investigates
Report
10/31
04:30 pm
rvnc
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Revance Therapeutics, Inc. - RVNC
Low Report
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Revance Therapeutics, Inc. - RVNC
Report
10/30
10:00 am
rvnc
ATTENTION RVNC SHAREHOLDERS: Investors who lost money on Revance Therapeutics, Inc. are urged to contact Levi & Korsinsky about an ongoing investigation
Low Report
ATTENTION RVNC SHAREHOLDERS: Investors who lost money on Revance Therapeutics, Inc. are urged to contact Levi & Korsinsky about an ongoing investigation
Report
10/30
09:30 am
rvnc
Lost Money on Revance Therapeutics, Inc. (RVNC)? You May Have Been Affected by Fraud - Contact Levi & Korsinsky
Low Report
Lost Money on Revance Therapeutics, Inc. (RVNC)? You May Have Been Affected by Fraud - Contact Levi & Korsinsky
Report
10/30
09:00 am
rvnc
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RVNC, CPTN, RCM on Behalf of Shareholders
Low Report
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RVNC, CPTN, RCM on Behalf of Shareholders
Report
10/29
01:15 pm
rvnc
Revance Therapeutics, Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Revance Therapeutics, Inc. (RVNC)
Low Report
Revance Therapeutics, Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Revance Therapeutics, Inc. (RVNC)
Report
10/29
12:00 pm
rvnc
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Revance Therapeutics, Inc. - RVNC
Low Report
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Revance Therapeutics, Inc. - RVNC
Report
Latest Posts

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day
Information

Information

Support

Support

Contact us

Contact us

11201 N Tatum Blvd
Suite 300-79795
Phoenix, AZ 85028
info@newsquantified.com

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

11201 N Tatum Blvd
Suite 300-79795
Phoenix, AZ 85028
info@newsquantified.com
Stay in the know news, product updates and promotions.
Copyright Ⓒ News Quanitifed LLC 2012-2024, All product trademarks, names, logos, and brands are property of their respective owners. Image(s) or Footage (as applicable), used under license from Shutterstock.com. 3.0.0